Why is Par Drugs & Che. falling/rising?

As of 18-Sep, Par Drugs & Chemicals Ltd is experiencing a price increase, with the current price at 118.56, reflecting a rise of 1.96 or 1.68%. The stock has shown strong performance today, outperforming its sector by 2.18%. In terms of returns, over the past week, the stock has increased by 4.39%, significantly higher than the Sensex's 1.67% gain. However, despite this recent uptick, the stock has a year-to-date decline of 40.39% and a one-year decline of 50.36%, indicating a challenging longer-term performance. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average, suggesting mixed signals in terms of momentum. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the stock's short-term performance over the past week has outpaced the benchmark index, the Sensex, which indicates a relative strength in the stock compared to the overall market. The Sensex has only gained 1.67% during the same period, while Par Drugs & Chemicals Ltd has achieved a return of 4.39%. This outperformance may reflect investor sentiment or specific developments related to the company, although the lack of detailed positive or negative factors limits a comprehensive analysis of the reasons behind the stock's recent rise.